date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.356066051742201.
The log-likelihood improved by 3.035.
Iteration 2 of at most 500:
Optimizing with step length 0.568633759351937.
The log-likelihood improved by 2.355.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 3.128.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.8022.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       18     1250     1080      782      329      382      333 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     310      204      159       77       42       12       11        2 
degree16 degree17 
       6        1 
1 
disease_progression 
H-positive risk:  832 862 130 891 464 118 849 458 131 71 129 65 
H-negative risk:  862 832 849 891 458 464 118 130 129 131 65 71 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
48 new agents 
2 
disease_progression 
H-positive risk:  838 858 132 887 463 120 856 452 132 70 127 65 
H-negative risk:  858 838 856 887 452 463 120 132 127 132 65 70 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
46 new agents 
3 
disease_progression 
H-positive risk:  843 862 134 888 456 121 856 448 133 70 124 65 
H-negative risk:  862 843 856 888 448 456 121 134 124 133 65 70 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
4 
disease_progression 
H-positive risk:  842 868 134 885 450 125 855 449 132 72 124 64 
H-negative risk:  868 842 855 885 449 450 125 134 124 132 64 72 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
58 new agents 
5 
disease_progression 
H-positive risk:  851 871 134 887 445 125 853 444 130 71 125 64 
H-negative risk:  871 851 853 887 444 445 125 134 125 130 64 71 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
54 new agents 
6 
disease_progression 
H-positive risk:  857 878 136 879 440 124 856 435 131 72 127 65 
H-negative risk:  878 857 856 879 435 440 124 136 127 131 65 72 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 8 

clinical_engagement 
diagnosis 
demography 
59 new agents 
7 
disease_progression 
H-positive risk:  862 883 139 873 438 124 862 427 132 68 129 63 
H-negative risk:  883 862 862 873 427 438 124 139 129 132 63 68 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 10 

clinical_engagement 
diagnosis 
demography 
65 new agents 
8 
disease_progression 
H-positive risk:  866 883 142 880 437 124 856 421 131 68 127 65 
H-negative risk:  883 866 856 880 421 437 124 142 127 131 65 68 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 10 2 

clinical_engagement 
diagnosis 
demography 
57 new agents 
9 
disease_progression 
H-positive risk:  870 889 143 876 434 124 859 417 133 67 123 65 
H-negative risk:  889 870 859 876 417 434 124 143 123 133 65 67 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 12 2 

clinical_engagement 
diagnosis 
demography 
63 new agents 
10 
disease_progression 
H-positive risk:  875 897 143 875 429 124 862 411 131 65 124 64 
H-negative risk:  897 875 862 875 411 429 124 143 124 131 64 65 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 16 2 

clinical_engagement 
diagnosis 
demography 
45 new agents 
11 
disease_progression 
H-positive risk:  883 903 144 869 428 125 859 408 131 64 124 62 
H-negative risk:  903 883 859 869 408 428 125 144 124 131 62 64 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 20 2 

clinical_engagement 
diagnosis 
demography 
70 new agents 
12 
disease_progression 
H-positive risk:  890 909 145 875 420 125 857 404 131 62 121 61 
H-negative risk:  909 890 857 875 404 420 125 145 121 131 61 62 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 21 2 

clinical_engagement 
diagnosis 
demography 
56 new agents 
13 
disease_progression 
H-positive risk:  827 824 135 963 414 113 916 406 146 62 131 63 
H-negative risk:  824 827 916 963 406 414 113 135 131 146 63 62 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 23 2 

clinical_engagement 
diagnosis 
demography 
229 new agents 
14 
disease_progression 
H-positive risk:  870 860 135 930 409 120 864 429 142 56 113 72 
H-negative risk:  860 870 864 930 429 409 120 135 113 142 72 56 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 29 3 

clinical_engagement 
diagnosis 
demography 
63 new agents 
15 
disease_progression 
H-positive risk:  880 865 136 927 406 120 858 427 141 56 112 72 
H-negative risk:  865 880 858 927 427 406 120 136 112 141 72 56 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 30 3 

clinical_engagement 
diagnosis 
demography 
53 new agents 
16 
disease_progression 
H-positive risk:  887 869 135 924 401 120 864 423 142 54 112 69 
H-negative risk:  869 887 864 924 423 401 120 135 112 142 69 54 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 30 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
17 
disease_progression 
H-positive risk:  897 866 133 917 401 121 871 417 140 54 113 70 
H-negative risk:  866 897 871 917 417 401 121 133 113 140 70 54 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 32 6 

clinical_engagement 
diagnosis 
demography 
74 new agents 
18 
disease_progression 
H-positive risk:  900 874 130 915 393 121 869 416 142 54 116 70 
H-negative risk:  874 900 869 915 416 393 121 130 116 142 70 54 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 33 6 

clinical_engagement 
diagnosis 
demography 
66 new agents 
19 
disease_progression 
H-positive risk:  909 881 130 908 390 121 875 410 141 52 112 71 
H-negative risk:  881 909 875 908 410 390 121 130 112 141 71 52 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 35 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
20 
disease_progression 
H-positive risk:  918 884 126 913 388 121 869 405 141 53 112 70 
H-negative risk:  884 918 869 913 405 388 121 126 112 141 70 53 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 38 6 

clinical_engagement 
diagnosis 
demography 
80 new agents 
21 
disease_progression 
H-positive risk:  925 891 127 916 384 119 870 401 139 51 110 67 
H-negative risk:  891 925 870 916 401 384 119 127 110 139 67 51 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 38 8 

clinical_engagement 
diagnosis 
demography 
73 new agents 
22 
disease_progression 
H-positive risk:  926 895 127 925 383 118 867 392 137 52 110 68 
H-negative risk:  895 926 867 925 392 383 118 127 110 137 68 52 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 37 8 

clinical_engagement 
diagnosis 
demography 
52 new agents 
23 
disease_progression 
H-positive risk:  932 898 127 929 385 118 863 385 135 52 109 67 
H-negative risk:  898 932 863 929 385 385 118 127 109 135 67 52 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 41 8 

clinical_engagement 
diagnosis 
demography 
67 new agents 
24 
disease_progression 
H-positive risk:  934 908 128 920 381 118 861 384 135 54 111 66 
H-negative risk:  908 934 861 920 384 381 118 128 111 135 66 54 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 43 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
25 
disease_progression 
H-positive risk:  856 844 117 992 381 110 931 383 145 54 122 65 
H-negative risk:  844 856 931 992 383 381 110 117 122 145 65 54 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 47 12 

clinical_engagement 
diagnosis 
demography 
195 new agents 
26 
disease_progression 
H-positive risk:  874 879 123 962 386 112 892 385 147 55 121 64 
H-negative risk:  879 874 892 962 385 386 112 123 121 147 64 55 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 52 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
27 
disease_progression 
H-positive risk:  887 879 121 957 385 111 887 392 148 50 119 64 
H-negative risk:  879 887 887 957 392 385 111 121 119 148 64 50 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 55 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
28 
disease_progression 
H-positive risk:  896 890 120 953 383 110 878 387 149 50 119 65 
H-negative risk:  890 896 878 953 387 383 110 120 119 149 65 50 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 57 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
29 
disease_progression 
H-positive risk:  893 897 121 957 378 113 875 379 152 49 120 66 
H-negative risk:  897 893 875 957 379 378 113 121 120 152 66 49 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 58 13 

clinical_engagement 
diagnosis 
demography 
54 new agents 
30 
disease_progression 
H-positive risk:  895 895 121 963 377 115 872 379 151 48 118 66 
H-negative risk:  895 895 872 963 379 377 115 121 118 151 66 48 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 61 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
31 
disease_progression 
H-positive risk:  898 895 123 962 374 114 878 378 152 46 117 63 
H-negative risk:  895 898 878 962 378 374 114 123 117 152 63 46 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 62 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
32 
disease_progression 
H-positive risk:  897 895 122 964 378 114 872 379 152 46 117 64 
H-negative risk:  895 897 872 964 379 378 114 122 117 152 64 46 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 61 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
33 
disease_progression 
H-positive risk:  901 899 123 958 371 116 874 381 153 46 115 63 
H-negative risk:  899 901 874 958 381 371 116 123 115 153 63 46 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 63 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
34 
disease_progression 
H-positive risk:  902 907 124 953 371 115 876 378 151 46 113 64 
H-negative risk:  907 902 876 953 378 371 115 124 113 151 64 46 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
57 new agents 
35 
disease_progression 
H-positive risk:  908 909 125 948 370 114 873 385 150 45 111 62 
H-negative risk:  909 908 873 948 385 370 114 125 111 150 62 45 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 63 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
36 
disease_progression 
H-positive risk:  910 923 124 943 360 114 877 378 152 46 113 60 
H-negative risk:  923 910 877 943 378 360 114 124 113 152 60 46 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
37 
disease_progression 
H-positive risk:  851 876 119 985 368 103 934 376 162 45 119 62 
H-negative risk:  876 851 934 985 376 368 103 119 119 162 62 45 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 67 18 

clinical_engagement 
diagnosis 
demography 
142 new agents 
38 
disease_progression 
H-positive risk:  867 881 122 965 386 106 908 382 158 45 119 61 
H-negative risk:  881 867 908 965 382 386 106 122 119 158 61 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
39 
disease_progression 
H-positive risk:  866 886 123 970 383 106 908 377 160 44 119 58 
H-negative risk:  886 866 908 970 377 383 106 123 119 160 58 44 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
40 
disease_progression 
H-positive risk:  864 887 122 966 387 106 911 373 161 44 121 58 
H-negative risk:  887 864 911 966 373 387 106 122 121 161 58 44 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
50 new agents 
41 
disease_progression 
H-positive risk:  865 890 124 960 380 110 913 371 161 43 123 60 
H-negative risk:  890 865 913 960 371 380 110 124 123 161 60 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
59 new agents 
42 
disease_progression 
H-positive risk:  868 894 126 964 375 113 913 365 160 40 123 59 
H-negative risk:  894 868 913 964 365 375 113 126 123 160 59 40 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
43 
disease_progression 
H-positive risk:  869 893 126 973 373 113 916 358 159 39 123 58 
H-negative risk:  893 869 916 973 358 373 113 126 123 159 58 39 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
44 
disease_progression 
H-positive risk:  871 904 126 967 369 113 917 361 159 38 123 52 
H-negative risk:  904 871 917 967 361 369 113 126 123 159 52 38 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
45 
disease_progression 
H-positive risk:  874 909 124 964 359 112 924 365 158 39 121 51 
H-negative risk:  909 874 924 964 365 359 112 124 121 158 51 39 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
46 
disease_progression 
H-positive risk:  886 904 126 972 355 112 922 353 158 38 122 52 
H-negative risk:  904 886 922 972 353 355 112 126 122 158 52 38 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
47 
disease_progression 
H-positive risk:  886 913 127 967 353 112 923 348 158 36 123 54 
H-negative risk:  913 886 923 967 348 353 112 127 123 158 54 36 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
53 new agents 
48 
disease_progression 
H-positive risk:  892 907 128 963 354 111 925 349 158 36 124 53 
H-negative risk:  907 892 925 963 349 354 111 128 124 158 53 36 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
49 
disease_progression 
H-positive risk:  841 827 118 1047 346 108 982 346 163 35 134 53 
H-negative risk:  827 841 982 1047 346 346 108 118 134 163 53 35 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
127 new agents 
50 
disease_progression 
H-positive risk:  836 834 120 1017 370 111 970 358 156 46 128 54 
H-negative risk:  834 836 970 1017 358 370 111 120 128 156 54 46 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
51 
disease_progression 
H-positive risk:  836 839 120 1016 371 111 970 352 156 48 128 53 
H-negative risk:  839 836 970 1016 352 371 111 120 128 156 53 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
52 
disease_progression 
H-positive risk:  843 839 123 1012 372 111 964 354 149 51 130 52 
H-negative risk:  839 843 964 1012 354 372 111 123 130 149 52 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
53 
disease_progression 
H-positive risk:  841 842 125 1004 373 111 973 346 150 53 131 51 
H-negative risk:  842 841 973 1004 346 373 111 125 131 150 51 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
54 
disease_progression 
H-positive risk:  847 847 124 998 372 110 976 345 150 54 129 48 
H-negative risk:  847 847 976 998 345 372 110 124 129 150 48 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
55 
disease_progression 
H-positive risk:  845 843 125 1002 371 109 978 345 151 52 127 52 
H-negative risk:  843 845 978 1002 345 371 109 125 127 151 52 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
50 new agents 
56 
disease_progression 
H-positive risk:  842 845 124 992 370 111 978 356 152 53 126 51 
H-negative risk:  845 842 978 992 356 370 111 124 126 152 51 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
57 
disease_progression 
H-positive risk:  846 845 124 980 376 111 976 359 152 52 125 54 
H-negative risk:  845 846 976 980 359 376 111 124 125 152 54 52 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
58 
disease_progression 
H-positive risk:  840 849 123 977 372 112 980 365 151 52 125 54 
H-negative risk:  849 840 980 977 365 372 112 123 125 151 54 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
59 
disease_progression 
H-positive risk:  853 847 119 979 372 112 973 365 151 52 123 54 
H-negative risk:  847 853 973 979 365 372 112 119 123 151 54 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
60 
disease_progression 
H-positive risk:  853 844 118 980 369 111 975 371 153 51 122 53 
H-negative risk:  844 853 975 980 371 369 111 118 122 153 53 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
61 
disease_progression 
H-positive risk:  810 793 115 1029 378 104 1013 366 158 52 128 54 
H-negative risk:  793 810 1013 1029 366 378 104 115 128 158 54 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
117 new agents 
62 
disease_progression 
H-positive risk:  816 800 110 1004 394 105 977 400 153 58 130 53 
H-negative risk:  800 816 977 1004 400 394 105 110 130 153 53 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
63 
disease_progression 
H-positive risk:  817 800 110 1002 392 108 980 398 152 59 132 50 
H-negative risk:  800 817 980 1002 398 392 108 110 132 152 50 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
64 
disease_progression 
H-positive risk:  816 795 111 1012 387 106 983 400 151 58 131 50 
H-negative risk:  795 816 983 1012 400 387 106 111 131 151 50 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
65 
disease_progression 
H-positive risk:  823 793 110 1011 378 102 981 405 156 57 129 55 
H-negative risk:  793 823 981 1011 405 378 102 110 129 156 55 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
66 
disease_progression 
H-positive risk:  822 796 110 1017 378 100 987 399 154 56 127 54 
H-negative risk:  796 822 987 1017 399 378 100 110 127 154 54 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
56 new agents 
67 
disease_progression 
H-positive risk:  820 798 110 1014 375 100 993 397 155 57 126 55 
H-negative risk:  798 820 993 1014 397 375 100 110 126 155 55 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
68 
disease_progression 
H-positive risk:  821 805 111 1011 375 102 985 397 152 58 128 55 
H-negative risk:  805 821 985 1011 397 375 102 111 128 152 55 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
69 
disease_progression 
H-positive risk:  822 802 113 1003 374 102 993 398 150 58 127 58 
H-negative risk:  802 822 993 1003 398 374 102 113 127 150 58 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
70 
disease_progression 
H-positive risk:  824 808 110 998 372 103 997 393 149 58 131 57 
H-negative risk:  808 824 997 998 393 372 103 110 131 149 57 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
71 
disease_progression 
H-positive risk:  823 814 110 997 371 106 995 391 148 60 126 59 
H-negative risk:  814 823 995 997 391 371 106 110 126 148 59 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
72 
disease_progression 
H-positive risk:  824 815 110 989 376 107 996 391 147 63 124 58 
H-negative risk:  815 824 996 989 391 376 107 110 124 147 58 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
73 
disease_progression 
H-positive risk:  788 773 100 1028 372 101 1046 385 151 64 133 59 
H-negative risk:  773 788 1046 1028 385 372 101 100 133 151 59 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
125 new agents 
74 
disease_progression 
H-positive risk:  791 770 100 1024 383 105 1024 400 148 66 128 61 
H-negative risk:  770 791 1024 1024 400 383 105 100 128 148 61 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
75 
disease_progression 
H-positive risk:  791 780 99 1025 375 107 1016 405 146 65 130 61 
H-negative risk:  780 791 1016 1025 405 375 107 99 130 146 61 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
76 
disease_progression 
H-positive risk:  788 785 101 1029 377 108 1006 398 149 65 129 65 
H-negative risk:  785 788 1006 1029 398 377 108 101 129 149 65 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
77 
disease_progression 
H-positive risk:  794 792 102 1023 379 107 1004 392 147 65 130 65 
H-negative risk:  792 794 1004 1023 392 379 107 102 130 147 65 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
78 
disease_progression 
H-positive risk:  795 790 102 1028 375 109 1005 393 144 66 131 62 
H-negative risk:  790 795 1005 1028 393 375 109 102 131 144 62 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
79 
disease_progression 
H-positive risk:  796 793 105 1017 373 108 1012 396 143 66 131 60 
H-negative risk:  793 796 1012 1017 396 373 108 105 131 143 60 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
80 
disease_progression 
H-positive risk:  799 797 104 1009 371 109 1008 407 139 67 132 58 
H-negative risk:  797 799 1008 1009 407 371 109 104 132 139 58 67 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
81 
disease_progression 
H-positive risk:  795 799 105 1007 371 109 1009 411 139 64 131 60 
H-negative risk:  799 795 1009 1007 411 371 109 105 131 139 60 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
82 
disease_progression 
H-positive risk:  787 802 106 1009 370 109 1018 410 138 62 130 59 
H-negative risk:  802 787 1018 1009 410 370 109 106 130 138 59 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
56 new agents 
83 
disease_progression 
H-positive risk:  782 803 106 1009 366 109 1025 408 141 61 131 59 
H-negative risk:  803 782 1025 1009 408 366 109 106 131 141 59 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
84 
disease_progression 
H-positive risk:  777 806 105 1003 371 110 1035 403 139 61 131 59 
H-negative risk:  806 777 1035 1003 403 371 110 105 131 139 59 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
85 
disease_progression 
H-positive risk:  740 767 100 1052 370 100 1071 399 146 60 136 59 
H-negative risk:  767 740 1071 1052 399 370 100 100 136 146 59 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
99 new agents 
86 
disease_progression 
H-positive risk:  740 767 100 1043 385 101 1069 402 145 57 134 57 
H-negative risk:  767 740 1069 1043 402 385 101 100 134 145 57 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
87 
disease_progression 
H-positive risk:  741 774 103 1045 383 102 1065 400 141 57 132 57 
H-negative risk:  774 741 1065 1045 400 383 102 103 132 141 57 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
88 
disease_progression 
H-positive risk:  739 776 102 1049 377 104 1071 395 141 57 131 58 
H-negative risk:  776 739 1071 1049 395 377 104 102 131 141 58 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
89 
disease_progression 
H-positive risk:  735 774 103 1045 378 103 1081 397 141 53 130 60 
H-negative risk:  774 735 1081 1045 397 378 103 103 130 141 60 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
90 
disease_progression 
H-positive risk:  738 779 103 1050 375 102 1070 398 142 52 132 59 
H-negative risk:  779 738 1070 1050 398 375 102 103 132 142 59 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
91 
disease_progression 
H-positive risk:  734 784 101 1048 375 103 1070 401 143 52 131 58 
H-negative risk:  784 734 1070 1048 401 375 103 101 131 143 58 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
92 
disease_progression 
H-positive risk:  739 774 102 1049 377 103 1072 401 140 52 131 60 
H-negative risk:  774 739 1072 1049 401 377 103 102 131 140 60 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
93 
disease_progression 
H-positive risk:  740 777 103 1054 369 107 1076 393 140 53 130 58 
H-negative risk:  777 740 1076 1054 393 369 107 103 130 140 58 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
94 
disease_progression 
H-positive risk:  733 784 103 1054 367 105 1081 398 140 51 130 54 
H-negative risk:  784 733 1081 1054 398 367 105 103 130 140 54 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
95 
disease_progression 
H-positive risk:  730 776 104 1057 371 107 1077 405 142 49 128 54 
H-negative risk:  776 730 1077 1057 405 371 107 104 128 142 54 49 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 97 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
96 
disease_progression 
H-positive risk:  730 778 103 1051 371 104 1080 406 140 51 131 55 
H-negative risk:  778 730 1080 1051 406 371 104 103 131 140 55 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 95 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
97 
disease_progression 
H-positive risk:  690 733 96 1102 365 98 1115 414 146 50 137 54 
H-negative risk:  733 690 1115 1102 414 365 98 96 137 146 54 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
101 new agents 
98 
disease_progression 
H-positive risk:  685 740 96 1082 373 97 1096 439 142 58 138 54 
H-negative risk:  740 685 1096 1082 439 373 97 96 138 142 54 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
99 
disease_progression 
H-positive risk:  692 735 95 1078 375 98 1110 431 138 58 135 55 
H-negative risk:  735 692 1110 1078 431 375 98 95 135 138 55 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
100 
disease_progression 
H-positive risk:  693 733 95 1085 373 101 1111 425 139 57 136 52 
H-negative risk:  733 693 1111 1085 425 373 101 95 136 139 52 57 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
101 
disease_progression 
H-positive risk:  693 736 95 1091 368 100 1109 428 139 57 132 52 
H-negative risk:  736 693 1109 1091 428 368 100 95 132 139 52 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
102 
disease_progression 
H-positive risk:  690 733 96 1091 365 102 1112 429 141 58 134 49 
H-negative risk:  733 690 1112 1091 429 365 102 96 134 141 49 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
103 
disease_progression 
H-positive risk:  691 730 96 1092 368 102 1112 423 145 58 134 49 
H-negative risk:  730 691 1112 1092 423 368 102 96 134 145 49 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
104 
disease_progression 
H-positive risk:  690 736 97 1092 365 102 1111 424 145 55 134 49 
H-negative risk:  736 690 1111 1092 424 365 102 97 134 145 49 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
105 
disease_progression 
H-positive risk:  695 735 99 1097 362 103 1103 423 144 52 136 51 
H-negative risk:  735 695 1103 1097 423 362 103 99 136 144 51 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
106 
disease_progression 
H-positive risk:  698 729 103 1105 363 104 1096 419 145 52 136 50 
H-negative risk:  729 698 1096 1105 419 363 104 103 136 145 50 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
107 
disease_progression 
H-positive risk:  699 733 103 1102 357 105 1090 429 142 51 137 52 
H-negative risk:  733 699 1090 1102 429 357 105 103 137 142 52 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
108 
disease_progression 
H-positive risk:  695 729 104 1116 353 107 1088 427 142 50 138 51 
H-negative risk:  729 695 1088 1116 427 353 107 104 138 142 51 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
109 
disease_progression 
H-positive risk:  644 697 93 1158 352 104 1138 421 146 50 147 50 
H-negative risk:  697 644 1138 1158 421 352 104 93 147 146 50 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
98 new agents 
110 
disease_progression 
H-positive risk:  649 701 92 1128 375 101 1124 437 146 47 149 51 
H-negative risk:  701 649 1124 1128 437 375 101 92 149 146 51 47 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
111 
disease_progression 
H-positive risk:  645 698 92 1127 378 101 1120 442 147 50 150 50 
H-negative risk:  698 645 1120 1127 442 378 101 92 150 147 50 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
112 
disease_progression 
H-positive risk:  647 701 89 1125 379 98 1125 437 149 50 151 49 
H-negative risk:  701 647 1125 1125 437 379 98 89 151 149 49 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
113 
disease_progression 
H-positive risk:  649 703 93 1130 368 100 1130 433 149 49 147 49 
H-negative risk:  703 649 1130 1130 433 368 100 93 147 149 49 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
114 
disease_progression 
H-positive risk:  646 695 92 1131 370 97 1139 433 150 47 149 51 
H-negative risk:  695 646 1139 1131 433 370 97 92 149 150 51 47 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
115 
disease_progression 
H-positive risk:  645 702 92 1128 370 94 1140 433 151 47 147 51 
H-negative risk:  702 645 1140 1128 433 370 94 92 147 151 51 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
116 
disease_progression 
H-positive risk:  653 692 92 1133 368 99 1143 426 153 46 143 52 
H-negative risk:  692 653 1143 1133 426 368 99 92 143 153 52 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
117 
disease_progression 
H-positive risk:  653 696 95 1130 367 98 1152 417 153 45 145 49 
H-negative risk:  696 653 1152 1130 417 367 98 95 145 153 49 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
118 
disease_progression 
H-positive risk:  654 698 96 1129 365 99 1151 421 150 45 146 46 
H-negative risk:  698 654 1151 1129 421 365 99 96 146 150 46 45 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
119 
disease_progression 
H-positive risk:  665 701 95 1121 366 96 1151 414 150 46 149 46 
H-negative risk:  701 665 1151 1121 414 366 96 95 149 150 46 46 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
120 
disease_progression 
H-positive risk:  667 698 95 1117 371 98 1153 408 151 48 149 45 
H-negative risk:  698 667 1153 1117 408 371 98 95 149 151 45 48 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
56 new agents 
121 
disease_progression 
H-positive risk:  625 661 91 1156 373 89 1192 408 156 47 157 45 
H-negative risk:  661 625 1192 1156 408 373 89 91 157 156 45 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
100 new agents 
122 
disease_progression 
H-positive risk:  631 661 88 1138 386 92 1186 416 152 44 160 46 
H-negative risk:  661 631 1186 1138 416 386 92 88 160 152 46 44 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
123 
disease_progression 
H-positive risk:  634 659 88 1141 390 92 1189 404 150 46 158 49 
H-negative risk:  659 634 1189 1141 404 390 92 88 158 150 49 46 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
124 
disease_progression 
H-positive risk:  640 662 89 1140 384 91 1192 398 151 46 160 47 
H-negative risk:  662 640 1192 1140 398 384 91 89 160 151 47 46 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
125 
disease_progression 
H-positive risk:  637 667 90 1138 388 93 1191 395 147 47 160 47 
H-negative risk:  667 637 1191 1138 395 388 93 90 160 147 47 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
126 
disease_progression 
H-positive risk:  651 670 88 1138 382 95 1181 392 146 49 162 46 
H-negative risk:  670 651 1181 1138 392 382 95 88 162 146 46 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
127 
disease_progression 
H-positive risk:  655 677 86 1133 381 95 1175 393 146 50 164 45 
H-negative risk:  677 655 1175 1133 393 381 95 86 164 146 45 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
128 
disease_progression 
H-positive risk:  658 674 87 1138 386 96 1178 383 143 51 163 43 
H-negative risk:  674 658 1178 1138 383 386 96 87 163 143 43 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
129 
disease_progression 
H-positive risk:  657 678 86 1135 394 94 1178 380 145 51 161 41 
H-negative risk:  678 657 1178 1135 380 394 94 86 161 145 41 51 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
130 
disease_progression 
H-positive risk:  650 677 89 1136 393 91 1191 377 144 50 163 39 
H-negative risk:  677 650 1191 1136 377 393 91 89 163 144 39 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
131 
disease_progression 
H-positive risk:  642 683 91 1139 392 92 1187 378 142 50 165 39 
H-negative risk:  683 642 1187 1139 378 392 92 91 165 142 39 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
132 
disease_progression 
H-positive risk:  643 679 91 1140 386 93 1193 378 145 49 166 37 
H-negative risk:  679 643 1193 1140 378 386 93 91 166 145 37 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
133 
disease_progression 
H-positive risk:  649 686 89 1144 383 93 1195 367 146 45 167 36 
H-negative risk:  686 649 1195 1144 367 383 93 89 167 146 36 45 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
134 
disease_progression 
H-positive risk:  650 680 89 1139 396 92 1192 368 145 50 160 39 
H-negative risk:  680 650 1192 1139 368 396 92 89 160 145 39 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
135 
disease_progression 
H-positive risk:  656 674 90 1145 395 93 1183 369 140 53 162 40 
H-negative risk:  674 656 1183 1145 369 395 93 90 162 140 40 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
136 
disease_progression 
H-positive risk:  657 669 89 1149 389 92 1181 380 140 54 163 37 
H-negative risk:  669 657 1181 1149 380 389 92 89 163 140 37 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
137 
disease_progression 
H-positive risk:  652 662 88 1160 385 94 1183 382 139 56 163 36 
H-negative risk:  662 652 1183 1160 382 385 94 88 163 139 36 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
138 
disease_progression 
H-positive risk:  647 666 89 1160 390 94 1182 383 136 60 157 36 
H-negative risk:  666 647 1182 1160 383 390 94 89 157 136 36 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
139 
disease_progression 
H-positive risk:  651 668 92 1145 389 97 1179 393 136 60 154 36 
H-negative risk:  668 651 1179 1145 393 389 97 92 154 136 36 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
140 
disease_progression 
H-positive risk:  647 668 92 1157 391 99 1176 386 135 57 154 38 
H-negative risk:  668 647 1176 1157 386 391 99 92 154 135 38 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
141 
disease_progression 
H-positive risk:  651 663 92 1150 385 99 1183 390 134 55 157 41 
H-negative risk:  663 651 1183 1150 390 385 99 92 157 134 41 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
142 
disease_progression 
H-positive risk:  644 661 91 1159 384 101 1179 389 132 56 158 46 
H-negative risk:  661 644 1179 1159 389 384 101 91 158 132 46 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
143 
disease_progression 
H-positive risk:  648 662 90 1159 380 99 1182 389 134 55 156 46 
H-negative risk:  662 648 1182 1159 389 380 99 90 156 134 46 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
144 
disease_progression 
H-positive risk:  641 661 92 1155 379 100 1186 400 131 55 157 43 
H-negative risk:  661 641 1186 1155 400 379 100 92 157 131 43 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
51 new agents 
145 
disease_progression 
H-positive risk:  644 657 89 1157 380 102 1185 403 130 53 156 44 
H-negative risk:  657 644 1185 1157 403 380 102 89 156 130 44 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
146 
disease_progression 
H-positive risk:  639 649 90 1146 385 105 1188 414 128 55 151 50 
H-negative risk:  649 639 1188 1146 414 385 105 90 151 128 50 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
147 
disease_progression 
H-positive risk:  639 658 91 1146 389 101 1182 416 123 56 150 49 
H-negative risk:  658 639 1182 1146 416 389 101 91 150 123 49 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
148 
disease_progression 
H-positive risk:  636 655 94 1143 399 101 1179 417 119 57 148 52 
H-negative risk:  655 636 1179 1143 417 399 101 94 148 119 52 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
149 
disease_progression 
H-positive risk:  634 646 94 1146 400 104 1179 422 121 55 149 50 
H-negative risk:  646 634 1179 1146 422 400 104 94 149 121 50 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
150 
disease_progression 
H-positive risk:  638 637 94 1154 402 107 1170 425 119 55 149 50 
H-negative risk:  637 638 1170 1154 425 402 107 94 149 119 50 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
151 
disease_progression 
H-positive risk:  641 641 92 1150 400 105 1178 417 120 55 153 48 
H-negative risk:  641 641 1178 1150 417 400 105 92 153 120 48 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
152 
disease_progression 
H-positive risk:  631 648 92 1150 400 103 1186 411 122 55 155 47 
H-negative risk:  648 631 1186 1150 411 400 103 92 155 122 47 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
153 
disease_progression 
H-positive risk:  633 652 92 1152 398 108 1177 412 119 54 157 46 
H-negative risk:  652 633 1177 1152 412 398 108 92 157 119 46 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
154 
disease_progression 
H-positive risk:  637 650 92 1151 395 111 1178 410 122 54 154 46 
H-negative risk:  650 637 1178 1151 410 395 111 92 154 122 46 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
155 
disease_progression 
H-positive risk:  628 652 92 1150 391 112 1190 402 125 56 157 45 
H-negative risk:  652 628 1190 1150 402 391 112 92 157 125 45 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
156 
disease_progression 
H-positive risk:  632 651 92 1141 400 113 1181 403 125 57 158 47 
H-negative risk:  651 632 1181 1141 403 400 113 92 158 125 47 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
157 
disease_progression 
H-positive risk:  629 655 94 1138 392 113 1188 403 127 58 156 47 
H-negative risk:  655 629 1188 1138 403 392 113 94 156 127 47 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
158 
disease_progression 
H-positive risk:  627 646 96 1153 393 113 1176 414 126 53 154 49 
H-negative risk:  646 627 1176 1153 414 393 113 96 154 126 49 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
159 
disease_progression 
H-positive risk:  634 642 98 1153 395 111 1175 407 128 55 152 50 
H-negative risk:  642 634 1175 1153 407 395 111 98 152 128 50 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
160 
disease_progression 
H-positive risk:  630 639 100 1147 394 109 1179 414 132 55 150 51 
H-negative risk:  639 630 1179 1147 414 394 109 100 150 132 51 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
161 
disease_progression 
H-positive risk:  626 646 101 1143 396 108 1181 410 137 54 149 49 
H-negative risk:  646 626 1181 1143 410 396 108 101 149 137 49 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
162 
disease_progression 
H-positive risk:  619 648 102 1137 404 108 1180 411 141 55 144 51 
H-negative risk:  648 619 1180 1137 411 404 108 102 144 141 51 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
163 
disease_progression 
H-positive risk:  618 647 104 1140 398 107 1183 410 146 55 142 50 
H-negative risk:  647 618 1183 1140 410 398 107 104 142 146 50 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
57 new agents 
164 
disease_progression 
H-positive risk:  616 648 105 1138 394 106 1185 413 148 56 141 50 
H-negative risk:  648 616 1185 1138 413 394 106 105 141 148 50 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
165 
disease_progression 
H-positive risk:  617 650 106 1134 397 107 1186 410 144 57 142 50 
H-negative risk:  650 617 1186 1134 410 397 107 106 142 144 50 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
166 
disease_progression 
H-positive risk:  625 644 107 1134 396 106 1174 423 143 55 141 52 
H-negative risk:  644 625 1174 1134 423 396 106 107 141 143 52 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
90 new agents 
167 
disease_progression 
H-positive risk:  633 655 106 1135 392 107 1177 407 141 52 141 54 
H-negative risk:  655 633 1177 1135 407 392 107 106 141 141 54 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
168 
disease_progression 
H-positive risk:  629 647 106 1136 399 105 1181 409 145 50 138 55 
H-negative risk:  647 629 1181 1136 409 399 105 106 138 145 55 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
169 
disease_progression 
H-positive risk:  630 647 111 1147 399 105 1173 405 144 47 138 54 
H-negative risk:  647 630 1173 1147 405 399 105 111 138 144 54 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
170 
disease_progression 
H-positive risk:  637 642 115 1141 396 109 1168 414 147 47 133 51 
H-negative risk:  642 637 1168 1141 414 396 109 115 133 147 51 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
171 
disease_progression 
H-positive risk:  638 647 114 1134 404 107 1167 408 148 48 134 51 
H-negative risk:  647 638 1167 1134 408 404 107 114 134 148 51 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
172 
disease_progression 
H-positive risk:  643 649 112 1137 401 108 1158 406 149 47 136 54 
H-negative risk:  649 643 1158 1137 406 401 108 112 136 149 54 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
173 
disease_progression 
H-positive risk:  648 654 110 1126 408 107 1156 402 147 49 138 55 
H-negative risk:  654 648 1156 1126 402 408 107 110 138 147 55 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
63 new agents 
174 
disease_progression 
H-positive risk:  654 657 110 1127 397 107 1158 405 144 48 138 55 
H-negative risk:  657 654 1158 1127 405 397 107 110 138 144 55 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
175 
disease_progression 
H-positive risk:  655 661 108 1131 395 106 1155 398 146 47 140 58 
H-negative risk:  661 655 1155 1131 398 395 106 108 140 146 58 47 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
176 
disease_progression 
H-positive risk:  658 658 108 1144 391 107 1152 392 143 47 141 59 
H-negative risk:  658 658 1152 1144 392 391 107 108 141 143 59 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
94 new agents 
177 
disease_progression 
H-positive risk:  659 663 110 1138 392 107 1149 392 147 47 137 59 
H-negative risk:  663 659 1149 1138 392 392 107 110 137 147 59 47 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 66 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
178 
disease_progression 
H-positive risk:  664 668 110 1137 396 106 1141 391 146 47 137 57 
H-negative risk:  668 664 1141 1137 391 396 106 110 137 146 57 47 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
179 
disease_progression 
H-positive risk:  674 669 111 1135 394 103 1134 391 148 46 138 57 
H-negative risk:  669 674 1134 1135 391 394 103 111 138 148 57 46 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
180 
disease_progression 
H-positive risk:  677 675 109 1126 396 102 1134 392 149 46 138 56 
H-negative risk:  675 677 1134 1126 392 396 102 109 138 149 56 46 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
90 new agents 
181 
disease_progression 
H-positive risk:  674 681 107 1135 396 100 1139 383 147 45 138 55 
H-negative risk:  681 674 1139 1135 383 396 100 107 138 147 55 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
182 
disease_progression 
H-positive risk:  674 673 108 1124 414 101 1128 393 147 46 137 55 
H-negative risk:  673 674 1128 1124 393 414 101 108 137 147 55 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
183 
disease_progression 
H-positive risk:  683 673 106 1130 406 103 1126 388 143 47 138 57 
H-negative risk:  673 683 1126 1130 388 406 103 106 138 143 57 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
184 
disease_progression 
H-positive risk:  686 671 103 1119 411 102 1128 388 147 47 141 57 
H-negative risk:  671 686 1128 1119 388 411 102 103 141 147 57 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
185 
disease_progression 
H-positive risk:  695 674 105 1111 417 101 1121 386 148 46 139 57 
H-negative risk:  674 695 1121 1111 386 417 101 105 139 148 57 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 69 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
186 
disease_progression 
H-positive risk:  686 678 105 1109 418 101 1125 386 152 43 138 59 
H-negative risk:  678 686 1125 1109 386 418 101 105 138 152 59 43 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
187 
disease_progression 
H-positive risk:  684 666 103 1122 417 100 1121 393 153 45 137 59 
H-negative risk:  666 684 1121 1122 393 417 100 103 137 153 59 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
188 
disease_progression 
H-positive risk:  686 657 104 1128 413 97 1126 394 154 46 137 58 
H-negative risk:  657 686 1126 1128 394 413 97 104 137 154 58 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
189 
disease_progression 
H-positive risk:  678 665 104 1134 412 96 1123 389 158 46 137 58 
H-negative risk:  665 678 1123 1134 389 412 96 104 137 158 58 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
190 
disease_progression 
H-positive risk:  681 662 104 1133 414 94 1116 397 159 47 136 57 
H-negative risk:  662 681 1116 1133 397 414 94 104 136 159 57 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
191 
disease_progression 
H-positive risk:  685 660 100 1134 412 95 1120 392 162 46 138 56 
H-negative risk:  660 685 1120 1134 392 412 95 100 138 162 56 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
192 
disease_progression 
H-positive risk:  687 664 102 1134 409 97 1122 389 158 45 138 55 
H-negative risk:  664 687 1122 1134 389 409 97 102 138 158 55 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
193 
disease_progression 
H-positive risk:  686 664 104 1126 410 97 1123 389 160 45 140 56 
H-negative risk:  664 686 1123 1126 389 410 97 104 140 160 56 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
95 new agents 
194 
disease_progression 
H-positive risk:  684 663 103 1111 417 98 1124 397 164 40 144 55 
H-negative risk:  663 684 1124 1111 397 417 98 103 144 164 55 40 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
195 
disease_progression 
H-positive risk:  681 673 105 1100 422 99 1122 392 164 43 144 55 
H-negative risk:  673 681 1122 1100 392 422 99 105 144 164 55 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
196 
disease_progression 
H-positive risk:  685 676 106 1096 428 100 1117 387 166 42 145 52 
H-negative risk:  676 685 1117 1096 387 428 100 106 145 166 52 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
197 
disease_progression 
H-positive risk:  684 676 108 1082 429 99 1128 386 167 45 145 51 
H-negative risk:  676 684 1128 1082 386 429 99 108 145 167 51 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
198 
disease_progression 
H-positive risk:  689 677 107 1087 430 100 1121 386 167 42 143 51 
H-negative risk:  677 689 1121 1087 386 430 100 107 143 167 51 42 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
199 
disease_progression 
H-positive risk:  688 672 105 1088 426 100 1135 381 166 41 148 50 
H-negative risk:  672 688 1135 1088 381 426 100 105 148 166 50 41 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
200 
disease_progression 
H-positive risk:  682 673 106 1082 432 101 1133 385 168 39 149 50 
H-negative risk:  673 682 1133 1082 385 432 101 106 149 168 50 39 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
201 
disease_progression 
H-positive risk:  685 672 100 1088 429 102 1125 388 169 39 153 50 
H-negative risk:  672 685 1125 1088 388 429 102 100 153 169 50 39 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
202 
disease_progression 
H-positive risk:  691 667 98 1092 422 104 1121 396 167 40 156 46 
H-negative risk:  667 691 1121 1092 396 422 104 98 156 167 46 40 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
203 
disease_progression 
H-positive risk:  694 673 97 1096 425 103 1117 389 167 42 152 45 
H-negative risk:  673 694 1117 1096 389 425 103 97 152 167 45 42 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
94 new agents 
204 
disease_progression 
H-positive risk:  700 681 100 1097 417 102 1102 396 166 43 149 47 
H-negative risk:  681 700 1102 1097 396 417 102 100 149 166 47 43 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
205 
disease_progression 
H-positive risk:  703 680 99 1095 418 100 1095 404 166 42 151 47 
H-negative risk:  680 703 1095 1095 404 418 100 99 151 166 47 42 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
206 
disease_progression 
H-positive risk:  700 682 100 1085 423 95 1094 413 169 45 149 45 
H-negative risk:  682 700 1094 1085 413 423 95 100 149 169 45 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
207 
disease_progression 
H-positive risk:  697 679 102 1091 417 93 1093 415 171 48 148 46 
H-negative risk:  679 697 1093 1091 415 417 93 102 148 171 46 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
208 
disease_progression 
H-positive risk:  709 680 100 1089 418 90 1079 423 167 51 148 46 
H-negative risk:  680 709 1079 1089 423 418 90 100 148 167 46 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
209 
disease_progression 
H-positive risk:  709 684 100 1093 410 90 1084 420 166 53 145 46 
H-negative risk:  684 709 1084 1093 420 410 90 100 145 166 46 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
210 
disease_progression 
H-positive risk:  714 691 102 1087 408 92 1076 419 166 53 146 46 
H-negative risk:  691 714 1076 1087 419 408 92 102 146 166 46 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
211 
disease_progression 
H-positive risk:  716 686 105 1081 418 91 1067 423 168 51 146 48 
H-negative risk:  686 716 1067 1081 423 418 91 105 146 168 48 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
212 
disease_progression 
H-positive risk:  720 694 105 1083 413 90 1057 426 167 54 143 48 
H-negative risk:  694 720 1057 1083 426 413 90 105 143 167 48 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
213 
disease_progression 
H-positive risk:  712 695 106 1081 406 87 1065 431 166 55 145 51 
H-negative risk:  695 712 1065 1081 431 406 87 106 145 166 51 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
214 
disease_progression 
H-positive risk:  709 701 104 1079 403 89 1068 426 167 57 148 49 
H-negative risk:  701 709 1068 1079 426 403 89 104 148 167 49 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
215 
disease_progression 
H-positive risk:  702 694 108 1098 389 88 1068 430 167 58 149 49 
H-negative risk:  694 702 1068 1098 430 389 88 108 149 167 49 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
91 new agents 
216 
disease_progression 
H-positive risk:  706 700 111 1088 383 92 1069 426 168 58 149 50 
H-negative risk:  700 706 1069 1088 426 383 92 111 149 168 50 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
217 
disease_progression 
H-positive risk:  700 690 116 1087 393 94 1068 425 168 56 150 53 
H-negative risk:  690 700 1068 1087 425 393 94 116 150 168 53 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
218 
disease_progression 
H-positive risk:  704 687 118 1077 397 91 1071 425 172 56 151 51 
H-negative risk:  687 704 1071 1077 425 397 91 118 151 172 51 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
219 
disease_progression 
H-positive risk:  712 691 118 1066 403 90 1055 426 172 59 153 55 
H-negative risk:  691 712 1055 1066 426 403 90 118 153 172 55 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
220 
disease_progression 
H-positive risk:  712 687 118 1078 401 92 1049 428 171 58 150 56 
H-negative risk:  687 712 1049 1078 428 401 92 118 150 171 56 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
55 new agents 
221 
disease_progression 
H-positive risk:  709 683 118 1081 410 91 1046 428 170 55 154 55 
H-negative risk:  683 709 1046 1081 428 410 91 118 154 170 55 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
222 
disease_progression 
H-positive risk:  718 689 118 1081 417 90 1032 428 169 53 152 53 
H-negative risk:  689 718 1032 1081 428 417 90 118 152 169 53 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
223 
disease_progression 
H-positive risk:  720 684 118 1096 419 97 1021 420 169 52 150 54 
H-negative risk:  684 720 1021 1096 420 419 97 118 150 169 54 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
224 
disease_progression 
H-positive risk:  719 682 114 1089 423 96 1023 426 171 51 152 54 
H-negative risk:  682 719 1023 1089 426 423 96 114 152 171 54 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
225 
disease_progression 
H-positive risk:  722 688 115 1087 420 95 1021 417 176 52 151 56 
H-negative risk:  688 722 1021 1087 417 420 95 115 151 176 56 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
226 
disease_progression 
H-positive risk:  722 692 114 1081 420 96 1030 411 173 55 152 54 
H-negative risk:  692 722 1030 1081 411 420 96 114 152 173 54 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
227 
disease_progression 
H-positive risk:  732 683 112 1081 424 95 1027 410 172 59 152 53 
H-negative risk:  683 732 1027 1081 410 424 95 112 152 172 53 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
228 
disease_progression 
H-positive risk:  733 683 112 1085 420 96 1027 403 176 58 154 53 
H-negative risk:  683 733 1027 1085 403 420 96 112 154 176 53 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
229 
disease_progression 
H-positive risk:  716 688 110 1085 426 94 1024 412 178 58 151 58 
H-negative risk:  688 716 1024 1085 412 426 94 110 151 178 58 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
230 
disease_progression 
H-positive risk:  715 690 112 1082 425 96 1024 409 180 58 150 59 
H-negative risk:  690 715 1024 1082 409 425 96 112 150 180 59 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
231 
disease_progression 
H-positive risk:  707 685 112 1081 424 97 1033 414 181 56 151 59 
H-negative risk:  685 707 1033 1081 414 424 97 112 151 181 59 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
232 
disease_progression 
H-positive risk:  703 676 111 1092 425 95 1039 411 181 56 155 56 
H-negative risk:  676 703 1039 1092 411 425 95 111 155 181 56 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
233 
disease_progression 
H-positive risk:  706 683 109 1078 421 96 1048 410 177 57 158 57 
H-negative risk:  683 706 1048 1078 410 421 96 109 158 177 57 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
234 
disease_progression 
H-positive risk:  703 678 110 1077 423 95 1053 413 178 56 158 56 
H-negative risk:  678 703 1053 1077 413 423 95 110 158 178 56 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
235 
disease_progression 
H-positive risk:  698 677 111 1082 418 95 1061 409 175 60 158 56 
H-negative risk:  677 698 1061 1082 409 418 95 111 158 175 56 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
236 
disease_progression 
H-positive risk:  689 680 114 1085 422 95 1062 405 177 59 158 54 
H-negative risk:  680 689 1062 1085 405 422 95 114 158 177 54 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
237 
disease_progression 
H-positive risk:  697 674 113 1090 424 94 1044 416 176 57 159 56 
H-negative risk:  674 697 1044 1090 416 424 94 113 159 176 56 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
238 
disease_progression 
H-positive risk:  691 674 107 1094 419 98 1053 412 180 55 161 56 
H-negative risk:  674 691 1053 1094 412 419 98 107 161 180 56 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
239 
disease_progression 
H-positive risk:  696 682 110 1089 424 101 1053 401 177 53 160 54 
H-negative risk:  682 696 1053 1089 401 424 101 110 160 177 54 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
240 
disease_progression 
H-positive risk:  695 687 108 1086 424 98 1055 403 178 54 158 54 
H-negative risk:  687 695 1055 1086 403 424 98 108 158 178 54 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 87 28 

clinical_engagement 
diagnosis 
demography 
61 new agents 
241 
disease_progression 
H-positive risk:  687 682 109 1090 430 98 1048 413 172 59 160 52 
H-negative risk:  682 687 1048 1090 413 430 98 109 160 172 52 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
87 new agents 
242 
disease_progression 
H-positive risk:  687 681 109 1088 429 99 1061 407 171 59 156 53 
H-negative risk:  681 687 1061 1088 407 429 99 109 156 171 53 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
243 
disease_progression 
H-positive risk:  679 679 110 1081 436 98 1074 407 171 58 152 55 
H-negative risk:  679 679 1074 1081 407 436 98 110 152 171 55 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
244 
disease_progression 
H-positive risk:  675 686 111 1080 434 99 1070 411 170 56 153 55 
H-negative risk:  686 675 1070 1080 411 434 99 111 153 170 55 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
245 
disease_progression 
H-positive risk:  682 690 114 1083 431 100 1056 412 172 55 152 53 
H-negative risk:  690 682 1056 1083 412 431 100 114 152 172 53 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
246 
disease_progression 
H-positive risk:  688 687 115 1084 435 103 1053 404 169 59 152 51 
H-negative risk:  687 688 1053 1084 404 435 103 115 152 169 51 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
247 
disease_progression 
H-positive risk:  688 690 115 1080 437 104 1048 408 167 61 154 48 
H-negative risk:  690 688 1048 1080 408 437 104 115 154 167 48 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
248 
disease_progression 
H-positive risk:  688 691 113 1082 438 105 1050 408 163 59 154 49 
H-negative risk:  691 688 1050 1082 408 438 105 113 154 163 49 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
249 
disease_progression 
H-positive risk:  686 687 113 1082 445 104 1051 410 163 56 151 52 
H-negative risk:  687 686 1051 1082 410 445 104 113 151 163 52 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
250 
disease_progression 
H-positive risk:  685 684 115 1091 437 102 1053 408 167 55 153 50 
H-negative risk:  684 685 1053 1091 408 437 102 115 153 167 50 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
251 
disease_progression 
H-positive risk:  681 684 115 1085 444 103 1051 411 167 56 153 50 
H-negative risk:  684 681 1051 1085 411 444 103 115 153 167 50 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
252 
disease_progression 
H-positive risk:  681 679 112 1080 442 104 1055 418 166 60 154 49 
H-negative risk:  679 681 1055 1080 418 442 104 112 154 166 49 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
253 
disease_progression 
H-positive risk:  684 677 114 1087 438 105 1053 417 164 60 153 48 
H-negative risk:  677 684 1053 1087 417 438 105 114 153 164 48 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
92 new agents 
254 
disease_progression 
H-positive risk:  691 684 110 1087 434 101 1047 423 163 59 155 46 
H-negative risk:  684 691 1047 1087 423 434 101 110 155 163 46 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
255 
disease_progression 
H-positive risk:  693 686 108 1091 430 100 1045 419 163 60 158 47 
H-negative risk:  686 693 1045 1091 419 430 100 108 158 163 47 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
256 
disease_progression 
H-positive risk:  692 685 108 1091 424 101 1057 420 161 60 159 42 
H-negative risk:  685 692 1057 1091 420 424 101 108 159 161 42 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
257 
disease_progression 
H-positive risk:  688 682 110 1097 418 99 1067 414 163 59 158 45 
H-negative risk:  682 688 1067 1097 414 418 99 110 158 163 45 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
258 
disease_progression 
H-positive risk:  688 686 106 1095 416 101 1066 414 163 58 158 49 
H-negative risk:  686 688 1066 1095 414 416 101 106 158 163 49 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
259 
disease_progression 
H-positive risk:  684 697 110 1087 418 104 1062 415 163 54 155 51 
H-negative risk:  697 684 1062 1087 415 418 104 110 155 163 51 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
260 
disease_progression 
H-positive risk:  680 695 110 1084 422 107 1065 420 156 57 152 52 
H-negative risk:  695 680 1065 1084 420 422 107 110 152 156 52 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
261 
disease_progression 
H-positive risk:  678 693 108 1089 426 105 1063 420 156 56 152 54 
H-negative risk:  693 678 1063 1089 420 426 105 108 152 156 54 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
262 
disease_progression 
H-positive risk:  676 688 108 1089 426 102 1071 422 158 54 154 52 
H-negative risk:  688 676 1071 1089 422 426 102 108 154 158 52 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
263 
disease_progression 
H-positive risk:  671 691 110 1089 435 99 1069 417 159 53 152 55 
H-negative risk:  691 671 1069 1089 417 435 99 110 152 159 55 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
264 
disease_progression 
H-positive risk:  670 696 110 1092 433 98 1069 416 158 52 152 54 
H-negative risk:  696 670 1069 1092 416 433 98 110 152 158 54 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
265 
disease_progression 
H-positive risk:  672 703 108 1098 428 97 1064 408 162 52 157 51 
H-negative risk:  703 672 1064 1098 408 428 97 108 157 162 51 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
266 
disease_progression 
H-positive risk:  670 707 106 1092 428 98 1068 411 161 51 161 47 
H-negative risk:  707 670 1068 1092 411 428 98 106 161 161 47 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
90 new agents 
267 
disease_progression 
H-positive risk:  664 710 103 1086 429 98 1074 411 163 53 164 45 
H-negative risk:  710 664 1074 1086 411 429 98 103 164 163 45 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
268 
disease_progression 
H-positive risk:  655 706 105 1079 432 97 1088 406 166 56 164 46 
H-negative risk:  706 655 1088 1079 406 432 97 105 164 166 46 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
269 
disease_progression 
H-positive risk:  650 702 103 1075 432 96 1095 409 168 57 164 49 
H-negative risk:  702 650 1095 1075 409 432 96 103 164 168 49 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
270 
disease_progression 
H-positive risk:  654 700 102 1081 418 94 1098 412 170 57 163 51 
H-negative risk:  700 654 1098 1081 412 418 94 102 163 170 51 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
271 
disease_progression 
H-positive risk:  653 700 100 1083 417 94 1103 405 170 54 169 52 
H-negative risk:  700 653 1103 1083 405 417 94 100 169 170 52 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
272 
disease_progression 
H-positive risk:  665 693 100 1093 412 96 1104 397 166 52 165 57 
H-negative risk:  693 665 1104 1093 397 412 96 100 165 166 57 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
273 
disease_progression 
H-positive risk:  667 693 97 1090 417 97 1090 406 163 53 171 56 
H-negative risk:  693 667 1090 1090 406 417 97 97 171 163 56 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
274 
disease_progression 
H-positive risk:  669 695 94 1087 421 96 1085 407 164 53 175 54 
H-negative risk:  695 669 1085 1087 407 421 96 94 175 164 54 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
275 
disease_progression 
H-positive risk:  671 700 93 1083 432 98 1067 412 162 52 176 54 
H-negative risk:  700 671 1067 1083 412 432 98 93 176 162 54 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
276 
disease_progression 
H-positive risk:  678 694 93 1078 434 100 1077 404 161 52 177 52 
H-negative risk:  694 678 1077 1078 404 434 100 93 177 161 52 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
277 
disease_progression 
H-positive risk:  681 680 89 1082 437 97 1080 411 164 50 177 52 
H-negative risk:  680 681 1080 1082 411 437 97 89 177 164 52 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
278 
disease_progression 
H-positive risk:  676 694 86 1078 441 99 1077 409 161 51 178 50 
H-negative risk:  694 676 1077 1078 409 441 99 86 178 161 50 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
279 
disease_progression 
H-positive risk:  681 697 86 1073 432 99 1075 410 163 55 179 50 
H-negative risk:  697 681 1075 1073 410 432 99 86 179 163 50 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
97 new agents 
280 
disease_progression 
H-positive risk:  682 706 84 1075 433 98 1071 406 163 54 174 54 
H-negative risk:  706 682 1071 1075 406 433 98 84 174 163 54 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
281 
disease_progression 
H-positive risk:  679 708 84 1068 436 97 1080 404 165 55 174 50 
H-negative risk:  708 679 1080 1068 404 436 97 84 174 165 50 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
282 
disease_progression 
H-positive risk:  675 705 84 1077 430 97 1077 408 166 56 175 50 
H-negative risk:  705 675 1077 1077 408 430 97 84 175 166 50 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
96 new agents 
283 
disease_progression 
H-positive risk:  678 704 84 1083 425 96 1069 413 167 55 173 53 
H-negative risk:  704 678 1069 1083 413 425 96 84 173 167 53 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
284 
disease_progression 
H-positive risk:  674 707 84 1086 427 96 1070 415 165 55 170 51 
H-negative risk:  707 674 1070 1086 415 427 96 84 170 165 51 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
285 
disease_progression 
H-positive risk:  683 709 82 1092 421 97 1065 412 163 50 176 50 
H-negative risk:  709 683 1065 1092 412 421 97 82 176 163 50 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
286 
disease_progression 
H-positive risk:  682 702 81 1090 432 98 1067 411 164 50 173 50 
H-negative risk:  702 682 1067 1090 411 432 98 81 173 164 50 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
287 
disease_progression 
H-positive risk:  683 704 82 1091 435 99 1060 410 162 49 171 54 
H-negative risk:  704 683 1060 1091 410 435 99 82 171 162 54 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
288 
disease_progression 
H-positive risk:  685 710 81 1076 441 99 1060 408 160 51 175 54 
H-negative risk:  710 685 1060 1076 408 441 99 81 175 160 54 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
289 
disease_progression 
H-positive risk:  686 714 84 1063 447 100 1066 404 156 51 172 57 
H-negative risk:  714 686 1066 1063 404 447 100 84 172 156 57 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
290 
disease_progression 
H-positive risk:  692 709 83 1060 443 104 1079 402 155 51 169 53 
H-negative risk:  709 692 1079 1060 402 443 104 83 169 155 53 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
291 
disease_progression 
H-positive risk:  693 707 86 1070 435 101 1083 394 159 49 169 54 
H-negative risk:  707 693 1083 1070 394 435 101 86 169 159 54 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
292 
disease_progression 
H-positive risk:  690 703 86 1071 438 97 1082 395 162 51 168 57 
H-negative risk:  703 690 1082 1071 395 438 97 86 168 162 57 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
293 
disease_progression 
H-positive risk:  693 704 83 1075 431 98 1087 394 158 52 167 58 
H-negative risk:  704 693 1087 1075 394 431 98 83 167 158 58 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
294 
disease_progression 
H-positive risk:  691 703 86 1068 422 100 1090 401 158 55 167 59 
H-negative risk:  703 691 1090 1068 401 422 100 86 167 158 59 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
93 new agents 
295 
disease_progression 
H-positive risk:  687 701 89 1070 419 101 1093 411 154 53 164 58 
H-negative risk:  701 687 1093 1070 411 419 101 89 164 154 58 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
296 
disease_progression 
H-positive risk:  687 701 90 1067 420 102 1092 415 152 54 163 57 
H-negative risk:  701 687 1092 1067 415 420 102 90 163 152 57 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
297 
disease_progression 
H-positive risk:  695 707 93 1066 418 102 1092 407 149 56 158 57 
H-negative risk:  707 695 1092 1066 407 418 102 93 158 149 57 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
298 
disease_progression 
H-positive risk:  690 703 94 1068 414 101 1098 410 147 59 155 61 
H-negative risk:  703 690 1098 1068 410 414 101 94 155 147 61 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
299 
disease_progression 
H-positive risk:  687 706 95 1076 405 101 1100 400 150 61 156 63 
H-negative risk:  706 687 1100 1076 400 405 101 95 156 150 63 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
300 
disease_progression 
H-positive risk:  687 703 102 1080 398 103 1100 405 145 63 154 60 
H-negative risk:  703 687 1100 1080 405 398 103 102 154 145 60 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
301 
disease_progression 
H-positive risk:  687 696 101 1095 394 102 1097 405 150 61 153 59 
H-negative risk:  696 687 1097 1095 405 394 102 101 153 150 59 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
302 
disease_progression 
H-positive risk:  685 697 101 1102 394 104 1099 394 147 62 157 58 
H-negative risk:  697 685 1099 1102 394 394 104 101 157 147 58 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 85 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
303 
disease_progression 
H-positive risk:  684 695 105 1098 396 104 1094 401 140 68 156 59 
H-negative risk:  695 684 1094 1098 401 396 104 105 156 140 59 68 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
304 
disease_progression 
H-positive risk:  686 694 105 1101 396 103 1095 399 137 66 159 59 
H-negative risk:  694 686 1095 1101 399 396 103 105 159 137 59 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
305 
disease_progression 
H-positive risk:  690 692 103 1096 400 101 1097 392 134 69 165 61 
H-negative risk:  692 690 1097 1096 392 400 101 103 165 134 61 69 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
306 
disease_progression 
H-positive risk:  679 684 105 1091 408 107 1111 393 132 67 163 60 
H-negative risk:  684 679 1111 1091 393 408 107 105 163 132 60 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
307 
disease_progression 
H-positive risk:  679 690 109 1090 411 104 1100 396 136 67 156 62 
H-negative risk:  690 679 1100 1090 396 411 104 109 156 136 62 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
308 
disease_progression 
H-positive risk:  679 696 110 1088 405 105 1094 400 138 67 156 62 
H-negative risk:  696 679 1094 1088 400 405 105 110 156 138 62 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
309 
disease_progression 
H-positive risk:  677 697 110 1089 403 103 1103 389 139 70 158 62 
H-negative risk:  697 677 1103 1089 389 403 103 110 158 139 62 70 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
310 
disease_progression 
H-positive risk:  667 699 111 1078 410 102 1108 397 138 69 159 62 
H-negative risk:  699 667 1108 1078 397 410 102 111 159 138 62 69 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
311 
disease_progression 
H-positive risk:  663 702 108 1080 409 102 1113 398 136 69 157 63 
H-negative risk:  702 663 1113 1080 398 409 102 108 157 136 63 69 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
312 
disease_progression 
H-positive risk:  667 705 103 1073 415 103 1112 396 136 66 163 61 
H-negative risk:  705 667 1112 1073 396 415 103 103 163 136 61 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
313 
disease_progression 
H-positive risk:  673 704 101 1062 422 102 1110 397 137 67 163 62 
H-negative risk:  704 673 1110 1062 397 422 102 101 163 137 62 67 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
314 
disease_progression 
H-positive risk:  669 696 100 1074 425 101 1105 396 139 64 167 64 
H-negative risk:  696 669 1105 1074 396 425 101 100 167 139 64 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
315 
disease_progression 
H-positive risk:  673 703 97 1072 423 103 1099 398 139 66 168 59 
H-negative risk:  703 673 1099 1072 398 423 103 97 168 139 59 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
88 new agents 
316 
disease_progression 
H-positive risk:  678 711 96 1065 418 105 1099 390 140 66 167 65 
H-negative risk:  711 678 1099 1065 390 418 105 96 167 140 65 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
317 
disease_progression 
H-positive risk:  679 715 97 1066 414 106 1104 387 140 64 167 61 
H-negative risk:  715 679 1104 1066 387 414 106 97 167 140 61 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
318 
disease_progression 
H-positive risk:  682 709 99 1061 416 109 1101 393 136 68 166 60 
H-negative risk:  709 682 1101 1061 393 416 109 99 166 136 60 68 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
319 
disease_progression 
H-positive risk:  683 718 99 1059 415 113 1101 385 136 65 170 56 
H-negative risk:  718 683 1101 1059 385 415 113 99 170 136 56 65 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
320 
disease_progression 
H-positive risk:  689 709 96 1062 421 114 1105 384 136 62 166 56 
H-negative risk:  709 689 1105 1062 384 421 114 96 166 136 56 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
321 
disease_progression 
H-positive risk:  685 712 95 1068 422 115 1101 381 136 64 164 57 
H-negative risk:  712 685 1101 1068 381 422 115 95 164 136 57 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
65 new agents 
322 
disease_progression 
H-positive risk:  682 711 97 1071 428 114 1100 383 135 62 162 55 
H-negative risk:  711 682 1100 1071 383 428 114 97 162 135 55 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
323 
disease_progression 
H-positive risk:  695 695 96 1075 431 113 1094 385 138 63 160 55 
H-negative risk:  695 695 1094 1075 385 431 113 96 160 138 55 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
324 
disease_progression 
H-positive risk:  697 698 101 1074 429 116 1084 389 141 62 154 55 
H-negative risk:  698 697 1084 1074 389 429 116 101 154 141 55 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
57 new agents 
325 
disease_progression 
H-positive risk:  700 706 100 1070 421 116 1081 391 144 63 153 55 
H-negative risk:  706 700 1081 1070 391 421 116 100 153 144 55 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
326 
disease_progression 
H-positive risk:  707 698 100 1067 417 118 1084 396 143 64 152 54 
H-negative risk:  698 707 1084 1067 396 417 118 100 152 143 54 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
91 new agents 
327 
disease_progression 
H-positive risk:  705 699 102 1060 425 117 1087 398 140 61 150 56 
H-negative risk:  699 705 1087 1060 398 425 117 102 150 140 56 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
328 
disease_progression 
H-positive risk:  710 691 106 1058 424 119 1083 397 148 59 150 55 
H-negative risk:  691 710 1083 1058 397 424 119 106 150 148 55 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
329 
disease_progression 
H-positive risk:  718 684 105 1055 420 118 1089 402 146 59 150 54 
H-negative risk:  684 718 1089 1055 402 420 118 105 150 146 54 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
330 
disease_progression 
H-positive risk:  709 689 103 1056 423 117 1090 406 148 59 150 50 
H-negative risk:  689 709 1090 1056 406 423 117 103 150 148 50 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
331 
disease_progression 
H-positive risk:  705 684 104 1062 425 116 1094 397 153 59 151 50 
H-negative risk:  684 705 1094 1062 397 425 116 104 151 153 50 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
332 
disease_progression 
H-positive risk:  714 684 103 1058 434 115 1089 391 156 59 146 51 
H-negative risk:  684 714 1089 1058 391 434 115 103 146 156 51 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
333 
disease_progression 
H-positive risk:  717 681 105 1056 434 115 1091 386 155 62 147 51 
H-negative risk:  681 717 1091 1056 386 434 115 105 147 155 51 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
334 
disease_progression 
H-positive risk:  721 693 106 1057 429 113 1086 384 155 58 147 51 
H-negative risk:  693 721 1086 1057 384 429 113 106 147 155 51 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
335 
disease_progression 
H-positive risk:  723 689 104 1059 441 114 1079 386 155 55 144 51 
H-negative risk:  689 723 1079 1059 386 441 114 104 144 155 51 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
336 
disease_progression 
H-positive risk:  714 681 103 1068 437 121 1081 385 156 54 149 51 
H-negative risk:  681 714 1081 1068 385 437 121 103 149 156 51 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
337 
disease_progression 
H-positive risk:  714 677 101 1069 446 120 1078 383 154 54 154 50 
H-negative risk:  677 714 1078 1069 383 446 120 101 154 154 50 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
338 
disease_progression 
H-positive risk:  711 664 99 1076 446 117 1084 387 158 55 154 49 
H-negative risk:  664 711 1084 1076 387 446 117 99 154 158 49 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
339 
disease_progression 
H-positive risk:  719 661 103 1072 442 119 1079 389 159 59 149 49 
H-negative risk:  661 719 1079 1072 389 442 119 103 149 159 49 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
340 
disease_progression 
H-positive risk:  728 663 103 1066 443 122 1073 390 159 58 146 49 
H-negative risk:  663 728 1073 1066 390 443 122 103 146 159 49 58 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
341 
disease_progression 
H-positive risk:  716 665 106 1073 442 122 1082 380 158 59 146 51 
H-negative risk:  665 716 1082 1073 380 442 122 106 146 158 51 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
342 
disease_progression 
H-positive risk:  716 669 104 1076 438 115 1083 383 159 57 149 51 
H-negative risk:  669 716 1083 1076 383 438 115 104 149 159 51 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
343 
disease_progression 
H-positive risk:  706 661 106 1078 443 114 1084 393 157 58 149 51 
H-negative risk:  661 706 1084 1078 393 443 114 106 149 157 51 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
344 
disease_progression 
H-positive risk:  717 666 104 1071 442 113 1077 394 158 60 147 51 
H-negative risk:  666 717 1077 1071 394 442 113 104 147 158 51 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
345 
disease_progression 
H-positive risk:  717 658 103 1071 446 115 1088 391 156 59 148 48 
H-negative risk:  658 717 1088 1071 391 446 115 103 148 156 48 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
346 
disease_progression 
H-positive risk:  718 659 108 1074 434 117 1090 391 154 59 147 49 
H-negative risk:  659 718 1090 1074 391 434 117 108 147 154 49 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
347 
disease_progression 
H-positive risk:  710 663 104 1066 439 119 1099 391 154 58 150 47 
H-negative risk:  663 710 1099 1066 391 439 119 104 150 154 47 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
348 
disease_progression 
H-positive risk:  708 667 106 1060 439 118 1104 389 152 60 148 49 
H-negative risk:  667 708 1104 1060 389 439 118 106 148 152 49 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
349 
disease_progression 
H-positive risk:  706 669 106 1057 443 118 1104 387 152 60 148 50 
H-negative risk:  669 706 1104 1057 387 443 118 106 148 152 50 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
350 
disease_progression 
H-positive risk:  701 666 104 1060 448 116 1106 386 157 60 147 49 
H-negative risk:  666 701 1106 1060 386 448 116 104 147 157 49 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
351 
disease_progression 
H-positive risk:  700 669 105 1066 448 112 1109 372 159 62 146 52 
H-negative risk:  669 700 1109 1066 372 448 112 105 146 159 52 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
352 
disease_progression 
H-positive risk:  702 672 104 1065 448 112 1104 368 159 63 152 51 
H-negative risk:  672 702 1104 1065 368 448 112 104 152 159 51 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
353 
disease_progression 
H-positive risk:  697 664 105 1071 446 110 1102 374 161 65 154 51 
H-negative risk:  664 697 1102 1071 374 446 110 105 154 161 51 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
354 
disease_progression 
H-positive risk:  706 660 106 1075 439 105 1102 373 167 62 155 50 
H-negative risk:  660 706 1102 1075 373 439 105 106 155 167 50 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
355 
disease_progression 
H-positive risk:  710 655 104 1080 439 106 1096 377 165 62 156 50 
H-negative risk:  655 710 1096 1080 377 439 106 104 156 165 50 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
356 
disease_progression 
H-positive risk:  704 662 104 1085 432 102 1103 376 170 59 153 50 
H-negative risk:  662 704 1103 1085 376 432 102 104 153 170 50 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
357 
disease_progression 
H-positive risk:  701 662 104 1087 429 103 1110 374 169 58 154 49 
H-negative risk:  662 701 1110 1087 374 429 103 104 154 169 49 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
358 
disease_progression 
H-positive risk:  702 659 103 1082 436 102 1106 380 167 57 155 51 
H-negative risk:  659 702 1106 1082 380 436 102 103 155 167 51 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
359 
disease_progression 
H-positive risk:  702 658 104 1085 428 101 1098 392 165 57 157 53 
H-negative risk:  658 702 1098 1085 392 428 101 104 157 165 53 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
360 
disease_progression 
H-positive risk:  699 652 105 1084 432 100 1107 387 166 55 158 55 
H-negative risk:  652 699 1107 1084 387 432 100 105 158 166 55 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
52 new agents 
Time difference of 16.55554 mins
This is task 19
date
